Program Tracks
(Please click each Assembly for detailed program information)

Assembly 1 Leadership Summit of Regenerative Medicine & Stem Cells
-Rethinking Global Strategy, Law, Ethic, Tech Trend, Financing and Market Outlook

Assembly 2 Forum of Breaking Basic Researches on RMSC
-From Wisdom, Knowledge, Theory to Understanding and Decoding the Secrete Triad World of RMSC & Tissue Engineering

Assembly 3 Disruptive and Innovative Hi-Tech Summit
-Hottest RMSC Technologies and Innovations Generating Great Impacts on the Next Decade

Assembly 4 Smart Triad Bioprocessing Symposium
-Robust, High Yield, and High-Quality Production Processes of Stem Cells, Tissues and Regenerative Biotherapy

Assembly 5 Career & Business Development Forum
-Talents, Networking, Business, Investment, and Contribute to the Society

Assembly 6 Translational Regenerative Medicine and Stem Cell Engineering Forum
-Vigorously Developing the Regenerative Potentials and Applications for Healthy, Wealthy, Beautiful and Solemn Life

Assembly 7 Sino-X/Cross-Trait RMSC Partnership Forum
-Accelerating RMSC Scientific Research of Bilateral, Multilateral International or Regional Collaborations

Assembly 8 Case Studies on Current Trend of Chinese Stem Cell R&D
-Sharing Successful Experiences on Legal, Policy and Best Practices of Chinese Stem Cell R & D and Innovative Treatment

Assembly 9 Posters, Exposition and Matchmaking
-Sourcing Novel Products, New Methods and Technology, Instrument and Equipment, Innovative Treatment and Potential Project Partnership

Assembly 10 Social & Cultural Events
-Enjoying the Happy Time, Delicious Food, Unforgettable Friendship, Exotic Romance, Chinese Culture and Happy Tour

Chapter 19 Upstream/Downstream Stem Cell Bioprocessing

Time: 08:30-10:30, November 3, 2019 (Sunday);Place: Dalian International Conference Center, China

Chair

Dr. Dhinakar S. Kompala, Founder & CEO, Sudhin Biopharma Co., USA

Co-Chair

Call for Co-chair

08:30-08:35

Chair’s Introduction

08:35-09:00

Title: Biosafety Testing for ATMPs
Dr. Edmund Ang, Principal Scientist, Merck Pte. Ltd., Singapore

09:00-09:25

Speech Opportunity Available
Abstract and Biography:Submit Here

09:25-09:50

Title: Novel, Efficient Scale-up of Inclined Settlers for Perfusion Bioreactor Cultures" and Its Current Applications in Stem Cell Expansion, and Differentiation into Beta Islet Cells, and Their Purification with Our Single Use Plastic Settlers
Dr. Dhinakar S. Kompala, Founder & CEO, Sudhin Biopharma Co., USA

09:50-10:15

Speech Opportunity Available
Abstract and Biography:Submit Here

10:15-10:30

Coffee Break

Chapter 20 Manufacturing Technologies in Stem Cells

Time:08:30-10:30, November 3, 2019 (Sunday); Place: Dalian International Conference Center, China

Chair

Dr. Danny Huylebroeck, Professor, Erasmus MC, The Netherlands

Co-Chair

Call for Co-chair

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available
Abstract and Biography:Submit Here

09:00-09:25

Title: An Improved Bio Fabrication Process to Enhance Cell Survival of Cartilage Regeneration and Functionality of the Osteoarthritic Knee When Enriched with Bone Marrow Mesenchymal Stem Cells (MSC)
Dr. Jose Manuel Baena, Founder and CEO, BRECA Health Care and REGEMAT 3D, Spain

09:25-09:50

Speech Opportunity Available
Abstract and Biography:Submit Here

09:50-10:15

Title: Standardization of Herbal Drugs by Highperformance Thin-Layer
Dr. Kesri Nandan Sharma, Manipal University, India

10:15-10:30

Coffee Break

Chapter 21 Approaches in Tissue Engineering

Time:13:30-15:30, November 1, 2019 (Friday); Place:Dalian International Conference Center, China

Chair

Call for chair

Co-Chair

Call for Co-chair

13:30-13:35

Chair’s Introduction

13:35-14:00

Speech Opportunity Available
Abstract and Biography:Submit Here

14:00-14:25

Speech Opportunity Available
Abstract and Biography:Submit Here

14:25-14:50

Speech Opportunity Available
Abstract and Biography:Submit Here

14:50-15:15

Speech Opportunity Available
Abstract and Biography:Submit Here

15:15-15:30

Coffee Break

Chapter 22 Innovations in Regenerative Medicine Fabrication

Time:08:30-10:30, November 2, 2019 (Saturday); Place: Dalian International Conference Center, China

Chair

Dr. Fari Payvandi, CEO, Cellvio Biomedical LLC, USA

Co-Chair

Call for Co-chair

08:30-08:35

Chair’s Introduction

08:35-09:00

Speech Opportunity Available
Abstract and Biography:Submit Here

09:00-09:25

Speech Opportunity Available
Abstract and Biography:Submit Here

09:25-09:50

Title: Under Preparation
Dr. Fari Payvandi, CEO, Cellvio Biomedical LLC, USA

09:50-10:15

Speech Opportunity Available
Abstract and Biography:Submit Here

10:15-10:30

Coffee Break